These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3718732)

  • 1. [Measurement of siderinuria in thalassemia major].
    Camerini G; Voghenzi A; Kalapurackal M; Menghi G
    Boll Soc Ital Biol Sper; 1986 Feb; 62(2):181-4. PubMed ID: 3718732
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urine iron: comparative evaluation between a colorimetric method and atomic absorption spectrophotometry].
    Galdo Capotorti M; Toscano G; Pinto L
    Pediatria (Napoli); 1983; 91(4):397-402. PubMed ID: 6545403
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron excretion in thalassemia after the administration of chelating agents.
    Markum AH; Iskandar W; Keng KL; Odang O
    Paediatr Indones; 1969; 9(3):89-98. PubMed ID: 4981722
    [No Abstract]   [Full Text] [Related]  

  • 5. Urine iron excretion in beta-thalassemia trait.
    Camerini G; Voghenzi A; Kalapurackal M
    Boll Soc Ital Biol Sper; 1987 Apr; 63(4):317-21. PubMed ID: 3447608
    [No Abstract]   [Full Text] [Related]  

  • 6. [Desferrioxamine in thalassemia].
    Biener R; Freundlich E; Rachmilewitz E
    Harefuah; 1983 May; 104(10):438-40. PubMed ID: 6629159
    [No Abstract]   [Full Text] [Related]  

  • 7. Ascorbic acid and iron excretion in a thalassemic child.
    Hathirat P; Areekul S; Pleehachinda R; Tuntawiroon M
    Southeast Asian J Trop Med Public Health; 1983 Jun; 14(2):274. PubMed ID: 6635769
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron chelation with oral desferrioxamine.
    Callender ST; Weatherall DJ
    Lancet; 1980 Sep; 2(8196):689. PubMed ID: 6106796
    [No Abstract]   [Full Text] [Related]  

  • 9. Desferrioxamine induced urinary iron excretion in thalassemia.
    Dubey AP; Kumar S; Choudhury P; Talukdar B; Puri RK
    Indian Pediatr; 1993 Jun; 30(6):775-8. PubMed ID: 8132258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of 2,3-dihydroxybenzoic acid (2,3-DHB) on the elimination of iron in a patient with beta-thalassemia major].
    Jensen M; Bender Ch
    Monatsschr Kinderheilkd (1902); 1977 May; 125(5):587. PubMed ID: 876248
    [No Abstract]   [Full Text] [Related]  

  • 11. [Atomic absorption spectrophotometry in the study of iron, copper and zinc blood levels in children with thalassemia].
    Moggi C; Poggini G
    Riv Clin Pediatr; 1968; 81(5):696-9. PubMed ID: 5740196
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of desferrioxamine-induced sideruria and measurement of labile iron store as indices of body iron status.
    Singh AK
    J Med; 1971; 2(6):345-62. PubMed ID: 5292126
    [No Abstract]   [Full Text] [Related]  

  • 13. Reduction of iron overload in thalassemia.
    Piomelli S; Graziano J
    Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical management of beta-thalassemia.
    Graziano J; Piomelli S
    Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
    [No Abstract]   [Full Text] [Related]  

  • 15. Spleen iron content is low in thalassemia.
    Borgna-Pignatti C; De Stefano P; Bongo IG; Avato F; Cazzola M
    Am J Pediatr Hematol Oncol; 1984; 6(3):340-3. PubMed ID: 6517228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Desferrioxamine-B in the diagnosis of hemosiderotic states and in the therapy of thalassemia. Apropos of 2 cases].
    De Luca G; Faelli U; Petrussa I
    Minerva Pediatr; 1966 Oct; 18(32):1920-5. PubMed ID: 5993655
    [No Abstract]   [Full Text] [Related]  

  • 17. [Qualitative and quantitative aminoaciduria in thalassemia major].
    Ventrelli I; Varone D; Borgatti L; Vierucci A
    Boll Soc Ital Biol Sper; 1965 Feb; 41(4):157-8. PubMed ID: 5876744
    [No Abstract]   [Full Text] [Related]  

  • 18. [Siderinuria caused by deferoxamine. II. The siderinuric increment obtained by association with ascorbic acid].
    Cartei G; Chisesi T; Cazzavillan M; Battista R; Barbui T; Dini E
    Haematologica; 1973; 58(11):671-88. PubMed ID: 4203582
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of ascorbic acid on desferrioxamine-induced siderinuria].
    Bosello O; Mengoli C; Rossi G
    Fracastoro; 1971; 64(5):310-9. PubMed ID: 5151104
    [No Abstract]   [Full Text] [Related]  

  • 20. Compliance with iron-chelation treatment after bone marrow transplantation.
    Kontoghiorghes GJ
    Lancet; 1994 Mar; 343(8897):604-5. PubMed ID: 7906361
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.